Premium
Cabaletta Bio Inc (CABA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary techno... Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAAR, T cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CAAR T cell product candidate was designed based on the clinically validated and commercially approved Chimeric Antigen Receptor, or CAR, T cell technology that is marketed for the treatment of B cell cancers. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -1.6393442623 | 1.83 | 1.92 | 1.59 | 766915 | 1.78148959 | CS |
| 4 | -0.85 | -32.0754716981 | 2.65 | 2.8895 | 1.59 | 1290900 | 2.15256131 | CS |
| 12 | -0.95 | -34.5454545455 | 2.75 | 2.8895 | 1.59 | 1364147 | 2.33323813 | CS |
| 26 | -2.61 | -59.1836734694 | 4.41 | 5.46 | 1.59 | 1835144 | 3.10396012 | CS |
| 52 | -20.54 | -91.9427036705 | 22.34 | 22.745 | 1.59 | 1522000 | 6.06437145 | CS |
| 156 | 0.04 | 2.27272727273 | 1.76 | 26.35 | 0.59 | 1036334 | 7.78376573 | CS |
| 260 | -11.33 | -86.290936786 | 13.13 | 26.35 | 0.59 | 691629 | 7.80519147 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
